O

Lab Platform

The MagIA Lab Platform, M-for-Lab, comprises a compact analyzer (measuring 35x28x25cm) and a dedicated 96-well cartridge designed in accordance with the SDS standard. This solution performs MagIA’s no-wash immunoassay within just 30 minutes and seamlessly interfaces with standard multi-channel pipettes and pipetting robots

Bioprocess monitoring

In its initial application, M-for-Lab has been tailored to monitor the Active Product Ingredient in bioprocess developments, functioning as a Process Analytical Technology (PAT). This stands in contrast to traditional ELISA procedures performed in analytical laboratories, which are time-consuming and result in prolonged bioprocess R&D lead-times. M-for-Lab has already demonstrated successful applications in monoclonal antibody (mAb) and vaccine development, and it holds the potential for use in recombinant protein development, gene therapy, and cell therapy processes.

Leveraging our no-wash technology, MagIA’s Lab Platform can be employed at-line, right beside a bioreactor, directly by the process development team itself. This facilitates swift decision-making and real-time monitoring of bioprocesses.

Non-contractual visuals / Product not CE marked

Lab Platform

The MagIA Lab Platform, M-for-Lab, comprises a compact analyzer (measuring 35x28x25cm) and a dedicated 96-well cartridge designed in accordance with the SDS standard. This solution performs MagIA’s no-wash immunoassay within just 30 minutes and seamlessly interfaces with standard multi-channel pipettes and pipetting robots

Bioprocess monitoring

In its initial application, M-for-Lab has been tailored to monitor the Active Product Ingredient in bioprocess developments, functioning as a Process Analytical Technology (PAT). This stands in contrast to traditional ELISA procedures performed in analytical laboratories, which are time-consuming and result in prolonged bioprocess R&D lead-times. M-for-Lab has already demonstrated successful applications in monoclonal antibody (mAb) and vaccine development, and it holds the potential for use in recombinant protein development, gene therapy, and cell therapy processes.

Leveraging our no-wash technology, MagIA’s Lab Platform can be employed at-line, right beside a bioreactor, directly by the process development team itself. This facilitates swift decision-making and real-time monitoring of bioprocesses.

Non-contractual visuals / Product not CE marked

O

Key advantages

A highly reliable fast and custom immunoassay at the side of your bioreactor

Simple : Can be performed by non-analytical technician with high inter-operator reproducibility

Quantitative and sensitive: Comparable to existing ELISAs

Custom kit development : Can be designed to your application from existing ELISAs & antibodies

Small foot print : 36*28cm 

Small volumes : 10-25 µl 

Easy to use : Can be performed by non-analytical technician with high inter-operator reproducibility

Quantitative and sensitive: Comparable to existing ELISAs

Custom kit development : Can be designed to your application from existing ELISAs & antibodies

Small foot print : 36*28cm

Small volumes : 10-25 µl

Download our

brochure here

+ 33 4 76 75 46 00

2017-2024 MagIA Diagnostics

Home

Diagnostics

Life sciences

About us

Contact us

News

Legal Notice

Cookies policy

Log in

+ 33 4 76 75 46 00 

2017-2024 MagIA Diagnostics

Home

Diagnostics

Life sciences

About us

Contact us

News

Legal Notice

Cookies policy

Log in

+ 33 4 76 75 46 00 

2017-2024 MagIA Diagnostics

Home

Diagnostics

Life sciences

About us

Contact us

News

Legal Notice

Cookies policy

Log in

Legal Notice

Cookies policy

+ 33 4 76 75 46 00 

contact@magia-diagnostics.com

2017-2024 MagIA Diagnostics